MedTrace Logo

Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China

NCT04952103 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-07-07

No results posted yet for this study

Summary

This study is a prospective, real world study.The objective is to observe the diagnosis and first-line treatment of Chinese patients with cancer of unknown primary, and collect the clinicopathological characteristics, treatment outcomes, survival and other data of the patients.

Conditions

  • Cancer of Unknown Primary Site

Interventions

OTHER

no intervention

The patient's treatment is determined by the physician in charge according to the patient's clinical situation and relevant guidelines, without additional intervention.

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-18
Primary Completion
2023-06-18
Completion
2024-06-18

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04952103 on ClinicalTrials.gov